Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride + luteinizing hormone + follitropin
- Development stage
- Approved
- Lead developer
- Ferring Pharmaceuticals
- Administration
- Subcutaneous, Intramuscular
01
Overview
A pharmaceutical gonadotropin combination product containing **luteinizing hormone** and **follitropin** with **sodium chloride** as a formulation component/diluent. In the fertility-treatment context provided, this refers to an injectable exogenous gonadotropin regimen used to stimulate ovarian follicular development in women with infertility, particularly in assisted reproduction. Follitropin acts as an agonist at the follicle-stimulating hormone receptor to promote granulosa-cell proliferation and follicular maturation, while luteinizing hormone activates the luteinizing hormone receptor to support theca-cell steroidogenesis, follicular maturation, and ovulatory processes. The exact commercial identity is not fully resolved from the provided name alone because the term is a component-level description rather than a clearly established marketed INN combination name.
- Brand names
- Menopur
- Other names
- sodium chloride + luteinizing hormone + follitropin
02
Targets
FSHR (Follicle-stimulating hormone receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)
Beyond the preview
Go deeper on sodium chloride + luteinizing hormone + follitropin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride + luteinizing hormone + follitropin.